Neural activity changes in the Supplementary Motor Area induced by dopaminergic treatment in parkinsonian patients

In this research, we study the neural activity changes in supplementary motor area (SMA) in patients with Parkinson's disease using functional magnetic resonance imaging (fMRI) and the effect of DOPA medication on neural activity. The correlation between the observed changes and motor improvement was also tested. Statistical parametric mapping was used to detect differences in the cortical activity when the pattern of parkinson's disease (PD) patients is compared with both the normal pattern and after DOPA supply. Patients show abnormal activation intensities in rostral and caudal supplementary motor area (SMA), which is normalized after dopaminergic pathways (DOPA) medication. The improvement in the clinical outcome correlated with an increase in fMRI signal, particularly with improvement of hypokinesia. The study indicates that cardinal symptoms in PD are associated with inappropriate underactivity in SMA.

[1]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[2]  N. Logothetis,et al.  Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.

[3]  F. Chollet,et al.  Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. , 2000, Brain : a journal of neurology.

[4]  Karl J. Friston,et al.  Movement‐Related effects in fMRI time‐series , 1996, Magnetic resonance in medicine.

[5]  N P Quinn,et al.  Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. , 1997, Brain : a journal of neurology.

[6]  A. Ceballos-Baumann.  Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT , 2003, Journal of Neurology.

[7]  T Uema,et al.  Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. , 1997, Brain : a journal of neurology.

[8]  Karl J. Friston,et al.  A direct quantitative relationship between the functional properties of human and macaque V5 , 2000, Nature Neuroscience.

[9]  Abbas F. Sadikot,et al.  Cerebral blood flow changes induced by subthalamic stimulation in Parkinson’s disease , 2003, Neurology.

[10]  Richard S. J. Frackowiak,et al.  Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study , 1992, Annals of neurology.

[11]  R. Turner,et al.  Functional magnetic resonance imaging of the human brain: data acquisition and analysis , 1998, Experimental Brain Research.

[12]  K. Uğurbil,et al.  Functional magnetic resonance imaging of the human brain , 1997, Journal of Neuroscience Methods.

[13]  U Sabatini,et al.  Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[14]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[15]  D. Guehl,et al.  Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia? , 2003, Brain : a journal of neurology.

[16]  Tzyy-Ping Jung,et al.  Assessing rCBF Changes in Parkinson’s Disease Using Independent Component Analysis , 2003 .

[17]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[18]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Ogawa.  Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .

[20]  Alberto Pupi,et al.  Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  A Dagher,et al.  Functional Imaging in Parkinson's Disease , 2001, Seminars in neurology.

[22]  M. Schwaiger,et al.  Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. , 2001, Brain : a journal of neurology.